Succinylcholine: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
== Contraindications | ''See [[critical care quick reference]] for drug doses by weight.'' | ||
==General== | |||
*Type: | |||
*Dosage Forms: | |||
*Common Trade Names: | |||
==Adult Dosing== | |||
==Pediatric Dosing== | |||
==Special Populations== | |||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | |||
*Lactation: | |||
*Renal Dosing | |||
**Adult | |||
**Pediatric | |||
*Hepatic Dosing | |||
**Adult | |||
**Pediatric | |||
==Contraindications== | |||
*Hyperkalemia | |||
*Preexisting hyperkalemia | |||
*Burns >5d old | |||
*Crush injury >5d old | |||
*Severe infection >5d old | |||
*Neuromuscular diseases (e.g. Myasthenia Gravis), myopathies | |||
*History of [[Malignant Hyperthermia]] | |||
*Allergy to class/drug | |||
==Adverse Reactions== | |||
===Serious=== | |||
===Common=== | |||
==Pharmacology== | |||
*Half-life: | |||
*Metabolism: | |||
*Excretion: | |||
*Mechanism of Action: | |||
==See Also== | ==See Also== | ||
| Line 12: | Line 45: | ||
*[[Critical care quick reference]] | *[[Critical care quick reference]] | ||
== | ==Sources== | ||
*Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis. | *Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis. | ||
<references/> | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 03:01, 24 February 2015
See critical care quick reference for drug doses by weight.
General
- Type:
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Hyperkalemia
- Preexisting hyperkalemia
- Burns >5d old
- Crush injury >5d old
- Severe infection >5d old
- Neuromuscular diseases (e.g. Myasthenia Gravis), myopathies
- History of Malignant Hyperthermia
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
See Also
Sources
- Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis.
